The CD133+ ependymal cells’ inability to self-renew makes them distinctly different from the AdpNSCs, which are able to self-renew in vivo, as illustrated by their expansion in number after LIF infusion and stroke. The gene discussed is PROM1; the disease is stroke disorder.